title: Cloning of the biosynthetic gene cluster for naphthoxanthene antibiotic FD-594 from Streptomyces sp. TA-0256.
abstract: FD-594 is an unique pyrano[4',3':6,7]naphtho[1,2-b]xanthene polyketide with a trisaccharide of 2,6-dideoxysugars. In this study, we cloned the FD-594 biosynthetic gene cluster from the producer strain Streptomyces sp. TA-0256 to investigate its biosynthesis. The identified pnx gene cluster was 38143 bp, consisting of 40 open reading frames, including a minimal PKS gene, TDP-olivose biosynthetic genes, two glycosyltransferase genes, two methyltransferase genes and many oxygenase/reductase genes. Most of these enzymes coded in the pnx cluster were reasonably assigned to a plausible biosynthetic pathway for FD-594, in which an unique ring opening process via Baeyer-Villiger-type oxidation catalyzed by a putative flavin adenine dinucleotide (FAD)-dependent monooxygenase, is speculated to lead to the unique xanthene structure. To clarify the involvement of pnx genes in the FD-594 biosynthesis, a glycosyltransferase, PnxGT2, and a methyltransferase, PnxMT2, were characterized enzymatically with the recombinant proteins expressed in Escherichia coli. As a result, PnxGT2 catalyzed the triple olivose transfers to the FD-594 aglycon with TDP-olivose as the glycosyl donor to afford triolivoside. Surprisingly, in the PnxGT2 enzymatic reaction, tetraolivoside and pentaolivoside were significantly detected along with the expected triolivoside. To our knowledge, PnxGT2 is the first contiguous oligosaccharide-forming glycosyltransferase in secondary metabolism. Furthermore, addition of PnxMT2 and S-adenosyl-L-methionine into the PnxGT2 reaction mixture afforded natural FD-594 to confirm that the PnxGT2 reaction product was the expected regiospecifically glycosylated compound. Consequently, the identified pnx gene cluster appears to be involved in FD-594 biosynthesis.
authors.affiliation: Department of Chemistry, Tokyo Institute of Technology, Tokyo, Japan.
authors.forename: Fumitaka
authors.initials: F
authors.lastname: Kudo
authors.forename: Takanori
authors.initials: T
authors.lastname: Yonezawa
authors.forename: Akiko
authors.initials: A
authors.lastname: Komatsubara
authors.forename: Kazutoshi
authors.initials: K
authors.lastname: Mizoue
authors.forename: Tadashi
authors.initials: T
authors.lastname: Eguchi
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000096:biosynthesis*; D003001:Cloning, Molecular; D004269:DNA, Bacterial / Q000737:chemistry / Q000235:genetics; D005798:Genes, Bacterial; D016695:Glycosyltransferases / Q000235:genetics / Q000378:metabolism; D008780:Methyltransferases / Q000235:genetics / Q000378:metabolism; D005810:Multigene Family; D016133:Polymerase Chain Reaction; D011714:Pyrans / Q000378:metabolism*; D017422:Sequence Analysis, DNA; D013302:Streptomyces / Q000235:genetics* / Q000378:metabolism*; D014966:Xanthenes / Q000378:metabolism*
chemical_list: D000903:Antibiotics, Antineoplastic; D004269:DNA, Bacterial; C112184:FD 594, antibiotic; D011714:Pyrans; D014966:Xanthenes; D008780:Methyltransferases; D016695:Glycosyltransferases